论文部分内容阅读
由于卵巢癌转移局限于腹腔,故国外已将放射性胶体腹腔内注射广泛用作卵巢癌术后辅助治疗。本文报道首都医院1966～1982年卵巢癌术后胶体~(32)P辅助治疗124例疗效,并选择最常见的卵巢乳头囊腺癌(Ⅰ组,37例)及恶性极高的卵巢内胚窦瘤(Ⅱ组,15例)为例,观察胶体~(32)P疗效并与相应对照组比较。结果表明Ⅰ、Ⅱ两治疗组的总存活率(54％、33％)均较相应对照组为高(31.4％、6％),Ⅰ、Ⅱ两治疗组的存活时间,即不同时间(<6月,6～12月,12～24月,>24月)存活率亦均较对照为高。因此作者等认为放射性胶样物可用
Due to ovarian cancer metastasis limited to the abdominal cavity, it has been abroad radioactive colloid intraperitoneal injection widely used as postoperative adjuvant treatment of ovarian cancer. This paper reports 124 cases of adjuvant treatment of ovarian cancer with colloid-32 P between 1966 and 1982 in Capital Hospital. The most common ovarian papillary cystadenocarcinoma (group Ⅰ, 37 cases) and malignant ovarian endoderm Tumor (Ⅱ group, 15 cases) as an example, the effect of colloid ~ (32) P was observed and compared with the corresponding control group. The results showed that the overall survival rate of the two treatment groups (54%, 33%) were higher than that of the corresponding control group (31.4%, 6%). The survival time of the two treatment groups Month, June to December, December to April,> 24 months) were also higher than the control. Therefore, the authors believe that radioactive rubber samples available